Myriad Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	124.4	149.6	102.4	132.1	56.9	257.4
Short-Term Investments	-	-	-	8.8	58	81.4
Cash & Short-Term Investments	124.4	149.6	102.4	140.9	114.9	338.8
Cash Growth	35.51%	46.09%	-27.32%	22.63%	-66.09%	124.82%
Accounts Receivable	123.8	115.3	121.2	114.3	101.6	91.3
Inventory	27.9	30.6	27.5	22	20.1	15.3
Other Current Assets	36.7	37.1	46.9	36.4	38	39.4
Total Current Assets	312.8	332.6	298	313.6	274.6	484.8
Net Property, Plant & Equipment	162.5	163.4	172.4	180.6	187.3	125.3
Other Intangible Assets	145.7	153.4	262.4	349.5	379.7	404.1
Goodwill	47.1	51.6	286.3	287.4	286.8	239.2
Long-Term Investments	-	-	-	-	54.8	59
Other Long-Term Assets	5.6	5.6	8.5	15.4	15.5	8.3
Total Assets	673.7	706.6	1,028	1,147	1,199	1,321
Accounts Payable	32.6	30	32.3	25.8	28.8	29.6
Accrued Expenses	90.5	96.9	119	113.9	94.3	161.7
Current Portion of Leases	7.1	6.9	12.8	16.2	14.1	13
Total Current Liabilities	130.2	133.8	164.1	155.9	137.2	204.3
Long-Term Debt	120.3	119.9	39.6	38.5	-	-
Long-Term Leases	84.1	83	87.9	97.4	130.9	79.3
Other Long-Term Liabilities	1.7	1.9	34.9	71.5	44.8	69.3
Total Long-Term Liabilities	206.1	204.8	162.4	207.4	175.7	148.6
Total Liabilities	336.3	338.6	326.5	363.3	312.9	352.9
Common Stock	0.9	0.9	0.9	0.9	0.8	0.8
Additional Paid-in Capital	1,493	1,489	1,458	1,416	1,260	1,226
Accumulated Other Comprehensive Income	0.7	0.8	-0.8	-3.7	-8.9	-5.1
Retained Earnings	-1,157	-1,123	-756.8	-629.5	-366.2	-254.2
Shareholders' Equity	337.4	368	701.1	783.2	885.8	967.8
Total Liabilities & Equity	673.7	706.6	1,028	1,147	1,199	1,321
Total Debt	211.5	209.8	140.3	152.1	145	92.3
Net Cash (Debt)	-87.1	-60.2	-37.9	-11.2	-30.1	246.5
Net Cash Per Share	-0.94	-0.65	-0.42	-0.14	-0.37	3.16
Book Value	337.4	368	701.1	783.2	885.8	967.8
Book Value Per Share	3.62	3.97	7.74	9.46	10.99	12.41
Tangible Book Value	144.6	163	152.4	146.3	219.3	324.5
Tangible Book Value Per Share	1.55	1.76	1.68	1.77	2.72	4.16

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q